From the start of next year onwards, Jacob Tolstrup will lead Lundbeck's sales and marketing activities across all of the pharmaceutical company's business areas when he takes on the role of chief commercial officer (CCO), the company reveals in a press release.
Peter Anastasiou, executive vice president for North America, has decided to leave the post at the end of the year to pursue another opportunity, the press release reports, meaning that Tolstrup can take on this market alongside the markets in the rest of the world, which he is already responsible for. Anastasiou has been the person responsible for the launch of migraine drug Vyepti.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.
Stallergenes slapped with injunction
There are still issues with Stallergenes Greer’s factory in Antony, the Agence Nationale de Sécurité du Médicament has concluded.
Overview: Pharma giants and Bavarian Nordic fight over billion-dollar vaccine market
There is currently no approved vaccine for RSV, which causes serious illness and can be deadly for newborns and the elderly. The race to come first to the vaccine market is heating up, while more companies are close to completing phase III studies. Get an overview of their progress here.
Eargo raises USD 100m from investment firm
US-based Eargo, which is run by a Dane, has entered an agreement with an investment firm which is injecting USD 100m into the company.
US authorities expand monkeypox vaccine plan
More Americans will be offered a monkeypox vaccine.
Corporate Quality Compliance Supporter - Digital QMS/IT Validation 
Director Regulatory Affairs 
Senior Toxicologist 
Chair of the Board 
Senior Clinical Trial Disclosure Associate 
Scientific Writer 
Regulatory Affairs Manager - Maternity Cover 
Principal Scientist – Pharmacology 
Senior Project Manager (GMP - Life Science) 
Global Learning Specialist 
Post Market Surveillance Department Manager 
Nordic Medical Advisor 
Training Supporter with high drive 
Medical Advisor